TLTFF

Theralase Technologies Inc.

 
Ordinary Shares International Reporting
OTCQX International OTCQX Advisor: Troutman Sanders LLP
Verified Company Profile 5/30/2017
Contact Info
  • 1945 Queen Street East
  • Suite 1240
  • Toronto, ONT M4L 1H7
  • Canada

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Mar 31, 2017 Quarterly Report
CIK 0000923883
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: Canada
Year of Inc. 1989
Employees 38 a/o May 06, 2017
Company Officers/Contacts
Roger Dumoulin-White CEO
Kristina Hachey CFO
Arkady Mandel CSO
Company Directors
Roger Dumoulin-White Chairman
Guy Anderson
Randy Good Bruder
Matthew Perraton
Company Notes
  • Formerly=InterStar Group Inc. until 11-04
  • Formerly=InterStar Mining Group Inc. until 11-03
Service Providers
OTCQX Advisor
Troutman Sanders LLP
875 Third Avenue
New York, NY, 10022
USA

Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Baker & McKenzie LLP
181 Bay Street, Suite 2100
Toronto, ONT, M5J 2T3
Canada

Investor Relations Firm
Not Available
TLTFF Security Details
Share Structure
Market Value1 $45,099,390 a/o Aug 15, 2017
Authorized Shares Unlimited a/o Dec 31, 2016
Outstanding Shares 124,206,526 a/o May 25, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 114,172,954 a/o May 15, 2017
Par Value No Par Value
Transfer Agent(s)
TSX Trust
Shareholders
Shareholders of Record 1,415 a/o Feb 27, 2014
Non US Stock Exchange Listing
TLT - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 196,492 (-0.51%)
Jul 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security